Medical Communications

Armo BioSciences only went public in January but it has already been snapped up by Eli Lilly for $1.6 billion. …

Anjali Shukla delves into the exciting, miniature world of nanorobotics to explore how the ground-breaking technology promises to change the …

At the request of the FDA, The US Department of Justice has launched legal action seeking to shut down stem …

Novartis payment to President Trump’s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning – with many asking …

The Spring 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …

Health and drug development-focused artificial intelligence firm BenevolentAI has announced that former UK Minister for Internet Security and Safety Joanna …

Simon Dingemans has been Chief Financial Officer at GSK since 2011 but has now chosen to retire from the position …

In the latest attempt to reverse its ailing fortunes and distance itself from its polluted brand, Canadian pharma firm Valeant …

Novartis has suddenly found itself embroiled in the Stormy Daniels affair, after the lawyer representing her, Michael Avenatti, included the …

Dr Matthew Fyfe, Head of Chemistry and Intellectual Property at TopiVert, gives an illuminating look into the latest developments in …

It’s Friday again and it’s been a week busy with companies’ financials. One company’s in particular were of note due …

The city of Los Angeles has levied legal action against a number of pharmaceutical firms for their role in advancing …

Mallinckrodt paid $80 million, with a further $345 million dependent on milestones, to acquire InfaCare in the hope that the …

It is timely to reflect on how we can best implement the revised GVP module (V) concerning risk management in …

Bristol-Myers Squibb has extended its existing collaboration with Flatiron Health by three years and expanded the efforts both will be …